Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Andy Chu
Affiliation
ORCID
Career Start Year
2006
Papers
14
H Index
11
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
28403581
Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
Oncotarget
2017
26271990
Large-scale profiling of microRNAs for The Cancer Genome Atlas.
Nucleic Acids Res
2016
27036018
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
Oncotarget
2016
26095338
Validation and calibration of next-generation sequencing to identify Epstein-Barr virus-positive gastric cancer in The Cancer Genome Atlas.
Gastric Cancer
2016
26061751
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
N Engl J Med
2015
25690954
Epigenetic and transcriptional determinants of the human breast.
Nat Commun
2015
25723320
Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients.
Genome Biol
2015
25109877
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.
Cell
2014
24534129
The expression level of small non-coding RNAs derived from the first exon of protein-coding genes is predictive of cancer status.
EMBO Rep
2014
25155756
The somatic genomic landscape of chromophobe renal cell carcinoma.
Cancer Cell
2014
23634996
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.
N Engl J Med
2013
23315977
Genome-wide microRNA and messenger RNA profiling in rodent liver development implicates mir302b and mir20a in repressing transforming growth factor-beta signaling.
Hepatology
2013
22832581
Subgroup-specific structural variation across 1,000 medulloblastoma genomes.
Nature
2012
16162365
A novel control scheme for inducing angiostatin-human IgG fusion protein production using recombinant CHO cells in a oscillating bioreactor.
Journal of Biotechnology
2006
1 - 14 of 14
Column Actions
Search
Recommended Authors
Collaborators
Marco A Marra
University of British Columbia
Co-authored papers
10
Andrew J Mungall
Co-authored papers
10
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers
9
Steven J M Jones
University of British Columbia
Co-authored papers
9
Richard A Moore
Co-authored papers
7
Jacqueline E Schein
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers
5
Nina Thiessen
Co-authored papers
5
Yussanne Ma
Co-authored papers
5
Reanne Bowlby
Co-authored papers
4
Denise Brooks
Co-authored papers
4
Peter W Laird
Van Andel Institute
Co-authored papers
4
Matthew Meyerson
Broad Institute
Co-authored papers
3
Eric Chuah
Co-authored papers
3
Andrew D Cherniack
Dana-Farber Cancer Institute
Co-authored papers
3
John N Weinstein
The University of Texas MD Anderson Cancer Center
Co-authored papers
3
Hui Shen
Van Andel Institute
Co-authored papers
3
Rehan Akbani
The University of Texas MD Anderson Cancer Center
Co-authored papers
3
Yongjun Zhao
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers
3
Robert A Holt
BC Cancer Research Institute
Co-authored papers
3
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers
3
Angela Tam
Co-authored papers
3
Payal Sipahimalani
Co-authored papers
3
Martin Hirst
University of British Columbia
Co-authored papers
2
Greg Eley
Co-authored papers
2
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers
2
Michael Mayo
Co-authored papers
2
Adrian Ally
Co-authored papers
2
Sahil Seth
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Erwin G Van Meir
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers
2
Jay Bowen
Nationwide Children's Hospital
Co-authored papers
2
1 - 30